Search Results - "Lisa B VanWagner"

Liver injury following SARS-CoV-2 vaccination: A multicenter case series by Shroff, Hersh, Satapathy, Sanjaya K., Crawford, James M., Todd, Nancy J., VanWagner, Lisa B.

Get full text

Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations by VanWagner, Lisa B., Harinstein, Matthew E., Runo, James R., Darling, Christopher, Serper, Marina, Hall, Shelley, Kobashigawa, Jon A., Hammel, Laura L.

“…Liver transplant (LT) candidates today are older, have greater medical severity of illness, and have more cardiovascular comorbidities than ever before. In…”
Get full text

Predictive performance of CAR-OLT and CAD-LT scores for post-transplant adverse cardiovascular events in a large transplant center by Tang, Helen, Shi, Christopher, Chapin, Sara, Panchal, Sarjukumar, Yu, Xiaoling, VanWagner, Lisa B, Serper, Marina, Mahmud, Nadim

Get full text

Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study by VanWagner, Lisa B, Ning, Hongyan, Lewis, Cora E, Shay, Christina M, Wilkins, John, Carr, J. Jeffrey, Terry, James G, Lloyd-Jones, Donald M, Jacobs, David R, Carnethon, Mercedes R

“…Abstract Objective Non-alcoholic fatty liver disease (NAFLD) is an obesity-related condition associated with cardiovascular mortality. Yet, whether or not…”
Get full text

Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study by VanWagner, Lisa B, Wilcox, Jane E, Ning, Hongyan, Lewis, Cora E, Carr, John Jeffrey, Rinella, Mary E, Shah, Sanjiv J, Lima, Joao A C, Lloyd-Jones, Donald M

“…Background Non-alcoholic fatty liver disease (NAFLD) is associated with high cardiovascular morbidity/mortality, including heart failure. Abnormalities in left…”
Get full text

Increasing prevalence of cirrhosis among insured adults in the United States, 2012-2018 by Ladner, Daniela P, Gmeiner, Michael, Hasjim, Bima J, Mazumder, Nikhilesh, Kang, Raymond, Parker, Emily, Stephen, John, Polineni, Praneet, Chorniy, Anna, Zhao, Lihui, VanWagner, Lisa B, Ackermann, Ronald T, Manski, Charles F

“…Liver cirrhosis is a chronic disease that is known as a "silent killer" and its true prevalence is difficult to describe. It is imperative to accurately…”
Get full text

Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study by Gerber, Yariv, VanWagner, Lisa B, Yaffe, Kristine, Terry, James G, Rana, Jamal S, Reis, Jared P, Sidney, Stephen

“…Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD) risk factors that have been linked to cognitive decline. Whether…”
Get full text

Body composition and muscle composition phenotypes in patients on waitlist and shortly after liver transplant - results from a pilot study by Forsgren, Mikael F, Pine, Stewart, Harrington, Claire Royalle, Gregory, Dyanna, Petersson, Mikael, Rinella, Mary, Leinhard, Olof Dahlqvist, VanWagner, Lisa B

“…Sarcopenia is common in end-stage liver disease and negatively impacts patients awaiting or undergoing liver transplantation (LT). Magnetic resonance imaging…”
Get full text

Dietary Patterns and Prevalent NAFLD at Year 25 from the Coronary Artery Risk Development in Young Adults (CARDIA) Study by Gray, Meagan E, Bae, Sejong, Ramachandran, Rekha, Baldwin, Nicholas, VanWagner, Lisa B, Jacobs, Jr, David R, Terry, James G, Shikany, James M

“…The prevalence of nonalcoholic fatty liver disease is rapidly rising. We aimed to investigate associations of diet quality and dietary patterns with…”
Get full text

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells by Jameson, Mark J, Beckler, Andrew D, Taniguchi, Linnea E, Allak, Amir, Vanwagner, Lisa B, Lee, Nora G, Thomsen, William C, Hubbard, Matthew A, Thomas, Christopher Y

“…Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) have poor efficacy in head and neck squamous carcinoma cells (HNSCC). Because the…”
Get full text

Non‐alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study by Mathew, Mahesh, Pope, Zachary C., Schreiner, Pamela J., Jacobs, David R., VanWagner, Lisa B., Terry, James G., Pereira, Mark A.

“…Background Non‐alcoholic fatty liver disease (NAFLD) is recognized as a prevalent determinant of cardiometabolic diseases. The association between NAFLD and…”
Get full text

Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study by Khanna, Sahil, Wilkins, John T., Ning, Hongyan, Allen, Norrina B., Lewis, Cora E., Carr, J. Jeffrey, Lloyd-Jones, Donald, VanWagner, Lisa B.

“…Objective. We evaluated the association of apolipoprotein B (apoB) with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol…”
Get full text

National Early Career Transplant Hepatologist Survey: Compensation, Burnout, and Job Satisfaction by Kriss, Michael, Te, Helen S., Verna, Elizabeth C., VanWagner, Lisa B., Scott, Frank I., Lai, Jennifer C.

“…Despite the growth of transplant hepatology as a subspecialty over the past decade, data on professional roles and compensation models remain lacking…”
Get full text

Diagnosis and Management of Hereditary Hemochromatosis by Cabrera, Elizabeth, Crespo, Gonzalo, VanWagner, Lisa B

“…This JAMA Insights Clinical Review discusses the diagnosis and management of hereditary hemochromatosis, including clinical and laboratory characteristics,…”
Get full text

Redefining Cirrhotic Cardiomyopathy for the Modern Era by Izzy, Manhal, VanWagner, Lisa B., Lin, Grace, Altieri, Mario, Findlay, James Y., Oh, Jae K., Watt, Kymberly D., Lee, Samuel S.

“…Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end‐stage liver disease in the absence of prior heart disease. First defined in 2005…”
Get full text

New insights into NAFLD and subclinical coronary atherosclerosis by VanWagner, Lisa B.

“…VanWagne discusses the new insights of non-alcoholic fatty liver disease (NAFLD) and its relation to subclinical coronary atherosclerosis. She mentions that…”
Get full text

Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy by Lemmer, Alexander, VanWagner, Lisa B., Ganger, Daniel

“…Congestive hepatopathy (CH) arises from chronically elevated right‐sided heart pressures transmitted to the liver by passive venous congestion. Over time, CH…”
Get full text

Preexisting Coronary Artery Disease in Liver Transplant Candidates: Risk Factor or Risk Marker? by Meurer, Lindsay, VanWagner, Lisa B.

Get full text

Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions by Barman, Pranab M., VanWagner, Lisa B.

“…In the changing landscape of liver transplantation (LT), we are now evaluating older and sicker patients with more cardiovascular comorbidities, and the…”
Get full text

Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies by Izzy, Manhal, VanWagner, Lisa B.

Get full text